BREAKING NEWS
The Royal Swedish Academy of Sciences has decided to award the 2026 #NobelPrize in Chemistry to Henri B. Kagan and Kenso Soai “for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis.”
Camizestrant is a SERD, not a PROTAC—but both point toward the same paradigm: degrade the disease-driving protein, not just inhibit it.
From inhibition → degradation → programmable protein degradation, medicinal chemistry is changing how we control biology.
🧪 Explore new chemical space with strained alicyclic building blocks from Orbiton Life Sciences.
Cyclopropane & cyclopentane derivatives ⚗️
📦 Stock available | 🌍 Worldwide supply
🔬 Custom synthesis & scale-up
#DrugDiscovery#MedicinalChemistry#Pharma
#Orbiton constantly strives to provide innovative chemistry solutions that help accelerate the success of our clients. WEBSITE: https://t.co/J1WZgWgRwU
A mea culpa: I should’ve posted on this review by @biogerontology and coworkers a long time ago. It’s a steely-eyed, unflinching look at the (published) state of generative AI in preclinical drug discovery with the critical eye of a medicinal chemist.
https://t.co/It3HNhFtkg
Indian Pharmacopoeia Commission (IPC) issued a drug safety alert about Meftal painkiller, stating that its constituent, mefenamic acid, can cause adverse reactions
Novel FDA Drug Approvals 3Q 2023 #medicine
It’s going to be a bumper year - 40 new drugs now approved by the FDA's Center for Drug Evaluation and Research (CDER)!